Welcome to LookChem.com Sign In|Join Free
  • or
Acetyl 4-azido-2,3,6-tri-O-acetyl-4-deoxy-α-D-glucopyranoside is a complex organic compound with the molecular formula C17H21N3O9. It is a derivative of a sugar molecule, specifically a deoxyglucose, which has had its hydroxyl groups at positions 2, 3, and 6 acetylated, and an azido group added at the 4 position. acetyl 4-azido-2,3,6-tri-O-acetyl-4-deoxy-α-D-glucopyranoside is of interest in chemical and pharmaceutical research due to its potential applications in the synthesis of various biologically active molecules and as a building block for the creation of complex carbohydrates. The acetyl groups serve to protect the hydroxyl groups during chemical reactions, allowing for selective modification of the molecule. acetyl 4-azido-2,3,6-tri-O-acetyl-4-deoxy-α-D-glucopyranoside's structure and reactivity make it a valuable tool in the field of organic synthesis, particularly in the preparation of glycoconjugates and other carbohydrate-derived compounds.

4098-00-4

Post Buying Request

4098-00-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4098-00-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4098-00-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,0,9 and 8 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 4098-00:
(6*4)+(5*0)+(4*9)+(3*8)+(2*0)+(1*0)=84
84 % 10 = 4
So 4098-00-4 is a valid CAS Registry Number.

4098-00-4Upstream product

4098-00-4Relevant academic research and scientific papers

Efficient synthesis of a galectin inhibitor clinical candidate (TD139) using a Payne rearrangement/azidation reaction cascade

Denavit, Vincent,Giguère, Denis,St-Gelais, Jacob

, p. 3903 - 3907 (2020)

Selective galectin inhibitors are valuable research tools and could also be used as drug candidates. In that context, TD139, a thiodigalactoside galectin-3 inhibitor, is currently being evaluated clinically for the treatment of idiopathic pulmonary fibrosis. Herein, we describe a new strategy for the preparation of TD139. Starting from inexpensive levoglucosan, we used a rarely employed reaction cascade: Payne rearrangement/azidation process leading to 3-azido-galactopyranose. The latter intermediate was efficiently converted into TD139 in a few simple and practical steps.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4098-00-4